Načítá se...
Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012
To evaluate the overall effectiveness of treatments for metastatic colorectal cancer, a meta-regression was undertaken in which randomized studies from 2000 to 2012 were evaluated and the temporal trend for both overall survival (OS) and progression-free survival (PFS) was determined. Our literature...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Co., Limited
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014792/ https://ncbi.nlm.nih.gov/pubmed/24829867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i2.191 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|